Abstract:Ossification of the posterior longitudinal ligament (OPLL), a spinal ligament, reduces the range of motion in limbs. No treatment is currently available for OPLL, which is why therapies are urgently needed. OPLL occurs in obesity, is more common in men, and has an onset after 40 years of age. The mechanisms underlying OPLL remain unclear. In this study, we performed a serum proteomic analysis in both OPLL patients and healthy subjects to identify factors potentially involved in the development of OPLL, and found reduced levels of a protein that might underlie the pathology of OPLL. We isolated the protein, determined its amino acid sequence, and identified it as chemokine (C-X-C motif) ligand 7 (CXCL7). Based on these proteomics findings, we generated a CXCL7 knockout mouse model to study the molecular mechanisms underlying OPLL. CXCL7-null mice presented with a phenotype of OPLL, showing motor impairment, heterotopic ossification in the posterior ligament tissue, and osteoporosis in vertebrate tissue. To identify the mechanisms of CXCL7 deficiency in OPLL, we searched for single nucleotide polymorphisms and altered DNA exons, but no abnormalities were found. Although miR-340 levels were found to be high in an miRNA array, they were insufficient to reduce CXCL7 levels. Ubiquitin C-terminal hydrolase1 (UCHL1) was found to be overexpressed in CXCL7-null mice and in the sera of patients with OPLL, and was correlated with OPLL severity. Post-translational modifications of proteins with ubiquitin and ubiquitin-like modifiers, orchestrated by a cascade of specialized ubiquitin activating enzyme (E1), ubiquitin conjugating enzyme (E2), and ubiquitin ligase (E3) enzymes, are thought to control a wide range of cellular processes, and alterations in the ubiquitin-proteasome system have been associated with several degenerative disorders. In addition, the OPLL tissue of CXCL7-null mouse and its primary cells expressed the antibody to ubiquitin (linkage-specific K48). Our data clearly show decreased CXCL7 levels in patients with OPLL, and that OPLL developed in mice lacking CXCL7. Tumor necrosis factor receptor-associated factor (TRAF)6 expression was decreased in CXCL7-null mouse primary cells. Furthermore, K48 polyubiquitination was found in posterior longitudinal ligament ossified tissue and primary cells from CXCL7-null mice. We performed a phosphoproteomics analysis in CXCL7-deficient mice and identified increased phosphorylation of mitogen-activated protein kinase kinase (ME3K)15, ubiquitin protein ligase E3C (UBE3C) and protein kinase C (PKC) alpha, suggesting that ubiquitin-dependent degradation is involved in CXCL7 deficiency. Future studies in the CXCL7-null mouse model are, therefore, warranted to investigate the role of ubiquitination in the onset of OPLL. In conclusion, CXCL7 levels may be useful as a serum marker for the progression of OPLL. This study also suggests that increasing CXCL7 levels in patients can serve as an effective therapeutic strategy for the treatment of OPLL.

Orthotopic ossification of the spinal ligaments of Zucker fatty rats: a possible animal model for ossification of the human posterior longitudinal ligament.

Combined use of leptin and mechanical stress has osteogenic effects on ossification of the posterior longitudinal ligament

Pathology of Ossification of the Posterior Longitudinal Ligament and Ligamentum Flavum

Development of a mouse model of chronic ventral spinal cord compression: Neurobehavioral, radiological, and pathological changes

Cyclic Tensile Stress to Rat Thoracolumbar Ligamentum Flavum Inducing the Ossification of Ligamentum Flavum

Recombinant Human Bone Morphogenetic Protein-2-induced Ossification of the Ligamentum Flavum in Rats and the Associated Global Modification of Histone H3.

Single-cell transcriptome profiling identifies the activation of type I interferon signaling in ossified posterior longitudinal ligament

Osteogenic lineage commitment of mesenchymal stem cells from patients with ossification of the posterior longitudinal ligament

Genetic insights into ossification of the posterior longitudinal ligament of the spine

Bone Morphogenetic Protein Receptors and Activin Receptors Are Highly Expressed in Ossified Ligament Tissues of Patients with Ossification of the Posterior Longitudinal Ligament.

Analysis of NOS1 , Lipid and Nissl Body in the Spina Bifida Occulta Spinal Cord

Title Osteogenic lineage commitment of mesenchymal stem cells from patients with ossification of the posterior longitudinal ligament

A large-scale genetic association study of ossification of the posterior longitudinal ligament of the spine

An in vivo model of ligamentum flavum hypertrophy from early‐stage inflammation to fibrosis

Expression and Localization of Bone Morphogenetic Proteins (bmps) and BMP Receptors in Ossification of the Ligamentum Flavum.

A genome-wide sib-pair linkage analysis of ossification of the posterior longitudinal ligament of the spine

Molecular Pathophysiology of Ossification of the Posterior Longitudinal Ligament (OPLL)

Establishment of a Rat Model for Osteoarthritis Resulting from Anterior Cruciate Ligament Rupture and Its Significance.

MicroRNA-181 regulates the development of Ossification of Posterior longitudinal ligament via Epigenetic Modulation by targeting PBX1

Ubiquitin-dependent proteolysis of CXCL7 leads to posterior longitudinal ligament ossification

Expression of calcitonin gene-related peptide induces ligament degeneration through endochondral ossification in osteoarthritis